Received Nov 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUCELVAX) | SEQIRUS, INC. | UNK | 406989 | IM / RA |
Patient received 2 doses of Influenza ccIIV3 6 months+ (Flucelvax); clinician consulted - was OK to move forward with no extended wait time following vaccination and advised patient that they may have a stronger immune response than normal.